Quadrant Capital Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-326
| Closed | -$8.05K | – | 2737 |
|
|
2024
Q3 | $8.05K | Hold |
326
| – | – | ﹤0.01% | 2204 |
|
|
2024
Q2 | $8.26K | Sell |
326
-190
| -37% | -$4.81K | ﹤0.01% | 2177 |
|
|
2024
Q1 | $13.1K | Buy |
516
+190
| +58% | +$4.83K | ﹤0.01% | 2003 |
|
|
2023
Q4 | $7.39K | Buy |
326
+270
| +482% | +$6.12K | ﹤0.01% | 2168 |
|
|
2023
Q3 | $1.04K | Sell |
56
-1,148
| -95% | -$21.4K | ﹤0.01% | 2483 |
|
|
2023
Q2 | $31.3K | Buy |
1,204
+40
| +3% | +$1.04K | ﹤0.01% | 1486 |
|
|
2023
Q1 | $33.4K | Buy |
1,164
+12
| +1% | +$345 | ﹤0.01% | 1448 |
|
|
2022
Q4 | $34.1K | Buy |
1,152
+80
| +7% | +$2.37K | ﹤0.01% | 1396 |
|
|
2022
Q3 | $26K | Buy |
1,072
+1,043
| +3,597% | +$25.3K | ﹤0.01% | 1400 |
|
|
2022
Q2 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 2315 |
|
|
2018
Q4 | – | Sell |
-20
| Closed | – | – | 2195 |
|
|
2018
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 2130 |
|
|
2018
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 2146 |
|
|
2018
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 2157 |
|
|
2017
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 1912 |
|
|
2017
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 1921 |
|
|
2017
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 1854 |
|
|
2017
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 2060 |
|
|
2016
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 1990 |
|
|
2016
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 1991 |
|
|
2016
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 1572 |
|
|
2016
Q1 | $0 | Buy |
+20
| New | – | ﹤0.01% | 1801 |
|